Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-25-033059

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Ann · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-24 Grant or award : show line 1 in the form Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X05/wk-form4_1750897515.xml…